Clinical Trials Browser

OTHER × Neoplasm Metastasis × LY3214996 × Clear all

NCT04534283 2024-08-07

A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.

Phase 2 Terminated

16 enrolled 11 charts

Neoplasm Metastasis, Neoplasms